NCT00840411View on ClinicalTrials.gov

Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Healthy
Interventions
DRUG

Clarithromycin ER 500 mg tablets

1 x 500 mg

DRUG

BIAXIN® XL 500 mg tablets

1 x 500 mg

Trial Locations (1)

63301

Gateway Medical Research, Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840411 - Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter